In-vivo xenograft murine human uveal melanoma model develops hepatic micrometastases

Hua Yang, Guofu Fang, Xinping Huang, Jie Yu, Chia Ling Hsieh, Hans E. Grossniklaus

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

The purpose of the study is to develop a mouse ocular melanoma model with human uveal melanoma cells that forms hepatic micrometastases. Human uveal melanoma Mel290 cells were transfected with a lentiviral-enhanced green fluorescent protein (EGFP) expression vector. Proliferation assays were performed by comparing Mel290-EGFP and Mel290 cells. After stable expression of EGFP and proliferation was ascertained, 1×10 Mel290-EGFP cells were introduced into NU/NU mice by posterior compartment (PC) inoculation or tail vein injection. Control groups were inoculated or injected with Mel290 cells. Ocular and hepatic frozen sections were examined by fluorescence microscopy, and the number of hepatic micrometastases was determined. EGFP expression was observed at 24 h after transfection. At 72 h after transfection, more than 70% of Mel290 cells expressed EGFP. At 45 days (six passages), 90% of Mel290 cells stably expressed EGFP. Histologic examination showed that Mel290-EGFP cells formed hepatic micrometastases after either PC inoculation or tail vein injection. A significant difference in the number of hepatic micrometastases between PC inoculation and tail vein injection (P<0.01) was observed. Mel290-EGFP cells stably expressed green fluorescent protein in vitro at 45 days (six passages). These cells formed hepatic micrometastases in NU/NU mice after PC inoculation or tail vein injection, with significantly more micrometastases developing in the PC inoculation model than after tail vein injection. © 2008 Lippincott Williams & Wilkins, Inc.

Original languageEnglish
Pages (from-to)95-103
Number of pages9
JournalMelanoma Research
Volume18
Issue number2
DOIs
Publication statusPublished - Apr 2008
Externally publishedYes

Fingerprint

Neoplasm Micrometastasis
Heterografts
Liver
Tail
Veins
Injections
Hepatocytes
Transfection
Uveal melanoma
enhanced green fluorescent protein
Frozen Sections
Green Fluorescent Proteins
Fluorescence Microscopy
Melanoma
Control Groups

Keywords

  • Animal model
  • Hepatic metastasis
  • Micrometastasis
  • Uveal melanoma

ASJC Scopus subject areas

  • Cancer Research
  • Dermatology

Cite this

In-vivo xenograft murine human uveal melanoma model develops hepatic micrometastases. / Yang, Hua; Fang, Guofu; Huang, Xinping; Yu, Jie; Hsieh, Chia Ling; Grossniklaus, Hans E.

In: Melanoma Research, Vol. 18, No. 2, 04.2008, p. 95-103.

Research output: Contribution to journalArticle

Yang, Hua ; Fang, Guofu ; Huang, Xinping ; Yu, Jie ; Hsieh, Chia Ling ; Grossniklaus, Hans E. / In-vivo xenograft murine human uveal melanoma model develops hepatic micrometastases. In: Melanoma Research. 2008 ; Vol. 18, No. 2. pp. 95-103.
@article{3a520d11b055443f8b238bdb13fff9d1,
title = "In-vivo xenograft murine human uveal melanoma model develops hepatic micrometastases",
abstract = "The purpose of the study is to develop a mouse ocular melanoma model with human uveal melanoma cells that forms hepatic micrometastases. Human uveal melanoma Mel290 cells were transfected with a lentiviral-enhanced green fluorescent protein (EGFP) expression vector. Proliferation assays were performed by comparing Mel290-EGFP and Mel290 cells. After stable expression of EGFP and proliferation was ascertained, 1×10 Mel290-EGFP cells were introduced into NU/NU mice by posterior compartment (PC) inoculation or tail vein injection. Control groups were inoculated or injected with Mel290 cells. Ocular and hepatic frozen sections were examined by fluorescence microscopy, and the number of hepatic micrometastases was determined. EGFP expression was observed at 24 h after transfection. At 72 h after transfection, more than 70{\%} of Mel290 cells expressed EGFP. At 45 days (six passages), 90{\%} of Mel290 cells stably expressed EGFP. Histologic examination showed that Mel290-EGFP cells formed hepatic micrometastases after either PC inoculation or tail vein injection. A significant difference in the number of hepatic micrometastases between PC inoculation and tail vein injection (P<0.01) was observed. Mel290-EGFP cells stably expressed green fluorescent protein in vitro at 45 days (six passages). These cells formed hepatic micrometastases in NU/NU mice after PC inoculation or tail vein injection, with significantly more micrometastases developing in the PC inoculation model than after tail vein injection. {\circledC} 2008 Lippincott Williams & Wilkins, Inc.",
keywords = "Animal model, Hepatic metastasis, Micrometastasis, Uveal melanoma",
author = "Hua Yang and Guofu Fang and Xinping Huang and Jie Yu and Hsieh, {Chia Ling} and Grossniklaus, {Hans E.}",
year = "2008",
month = "4",
doi = "10.1097/CMR.0b013e3282f628df",
language = "English",
volume = "18",
pages = "95--103",
journal = "Melanoma Research",
issn = "0960-8931",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - In-vivo xenograft murine human uveal melanoma model develops hepatic micrometastases

AU - Yang, Hua

AU - Fang, Guofu

AU - Huang, Xinping

AU - Yu, Jie

AU - Hsieh, Chia Ling

AU - Grossniklaus, Hans E.

PY - 2008/4

Y1 - 2008/4

N2 - The purpose of the study is to develop a mouse ocular melanoma model with human uveal melanoma cells that forms hepatic micrometastases. Human uveal melanoma Mel290 cells were transfected with a lentiviral-enhanced green fluorescent protein (EGFP) expression vector. Proliferation assays were performed by comparing Mel290-EGFP and Mel290 cells. After stable expression of EGFP and proliferation was ascertained, 1×10 Mel290-EGFP cells were introduced into NU/NU mice by posterior compartment (PC) inoculation or tail vein injection. Control groups were inoculated or injected with Mel290 cells. Ocular and hepatic frozen sections were examined by fluorescence microscopy, and the number of hepatic micrometastases was determined. EGFP expression was observed at 24 h after transfection. At 72 h after transfection, more than 70% of Mel290 cells expressed EGFP. At 45 days (six passages), 90% of Mel290 cells stably expressed EGFP. Histologic examination showed that Mel290-EGFP cells formed hepatic micrometastases after either PC inoculation or tail vein injection. A significant difference in the number of hepatic micrometastases between PC inoculation and tail vein injection (P<0.01) was observed. Mel290-EGFP cells stably expressed green fluorescent protein in vitro at 45 days (six passages). These cells formed hepatic micrometastases in NU/NU mice after PC inoculation or tail vein injection, with significantly more micrometastases developing in the PC inoculation model than after tail vein injection. © 2008 Lippincott Williams & Wilkins, Inc.

AB - The purpose of the study is to develop a mouse ocular melanoma model with human uveal melanoma cells that forms hepatic micrometastases. Human uveal melanoma Mel290 cells were transfected with a lentiviral-enhanced green fluorescent protein (EGFP) expression vector. Proliferation assays were performed by comparing Mel290-EGFP and Mel290 cells. After stable expression of EGFP and proliferation was ascertained, 1×10 Mel290-EGFP cells were introduced into NU/NU mice by posterior compartment (PC) inoculation or tail vein injection. Control groups were inoculated or injected with Mel290 cells. Ocular and hepatic frozen sections were examined by fluorescence microscopy, and the number of hepatic micrometastases was determined. EGFP expression was observed at 24 h after transfection. At 72 h after transfection, more than 70% of Mel290 cells expressed EGFP. At 45 days (six passages), 90% of Mel290 cells stably expressed EGFP. Histologic examination showed that Mel290-EGFP cells formed hepatic micrometastases after either PC inoculation or tail vein injection. A significant difference in the number of hepatic micrometastases between PC inoculation and tail vein injection (P<0.01) was observed. Mel290-EGFP cells stably expressed green fluorescent protein in vitro at 45 days (six passages). These cells formed hepatic micrometastases in NU/NU mice after PC inoculation or tail vein injection, with significantly more micrometastases developing in the PC inoculation model than after tail vein injection. © 2008 Lippincott Williams & Wilkins, Inc.

KW - Animal model

KW - Hepatic metastasis

KW - Micrometastasis

KW - Uveal melanoma

UR - http://www.scopus.com/inward/record.url?scp=40849142160&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40849142160&partnerID=8YFLogxK

U2 - 10.1097/CMR.0b013e3282f628df

DO - 10.1097/CMR.0b013e3282f628df

M3 - Article

VL - 18

SP - 95

EP - 103

JO - Melanoma Research

JF - Melanoma Research

SN - 0960-8931

IS - 2

ER -